tiprankstipranks
Trending News
More News >
Cytokinetics (CYTK)
NASDAQ:CYTK
US Market

Cytokinetics (CYTK) Income Statement

Compare
1,243 Followers

Cytokinetics Income Statement

Last quarter (Q4 2025), Cytokinetics's total revenue was $17.75M, an increase of 4.89% from the same quarter last year. In Q4, Cytokinetics's net income was $-183.03M. See Cytokinetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 88.04M$ 18.47M$ 7.53M$ 94.59M$ 70.43M
Gross Profit
$ 77.91M$ -320.93M$ -322.59M$ -146.22M$ -89.51M
Operating Expenses
$ 690.17M$ 215.31M$ 173.61M$ 177.98M$ 96.80M
Depreciation and Amortization
$ 9.69M$ 9.53M$ 11.89M$ 8.40M$ 9.64M
EBITDA
$ -775.27M$ -493.48M$ -456.68M$ -329.40M$ -176.34M
Operating Income
$ -612.26M$ -536.25M$ -496.20M$ -324.20M$ -186.31M
Other Income/Expenses
$ -172.70M$ -53.28M$ -30.04M$ -64.75M$ -29.00M
Pretax Income
$ -784.96M$ -589.53M$ -526.24M$ -388.95M$ -215.31M
Net Income
$ -784.96M$ -589.53M$ -526.24M$ -388.95M$ -215.31M
Per Share Metrics
Basic EPS
$ -6.54$ -5.26$ -5.45$ -4.33$ -2.80
Diluted EPS
$ -6.54$ -5.26$ -5.45$ -4.33$ -2.80
Weighted Average Shares Outstanding
120.02M 111.98M 96.52M 89.83M 76.89M
Weighted Average Shares Outstanding (Diluted)
120.10M 111.98M 96.52M 89.83M 76.89M
Currency in USD

Cytokinetics Earnings and Revenue History